QQQ   388.83 (-0.25%)
AAPL   189.95 (+0.31%)
MSFT   378.91 (+0.02%)
META   327.15 (-1.52%)
GOOGL   132.53 (-1.82%)
AMZN   146.09 (-0.16%)
TSLA   240.08 (-1.66%)
NVDA   467.70 (-2.85%)
NIO   7.28 (+1.39%)
BABA   74.86 (+0.25%)
AMD   121.16 (-2.17%)
T   16.57 (+1.66%)
F   10.28 (-2.93%)
MU   76.12 (-0.74%)
CGC   0.56 (+0.00%)
GE   121.74 (+2.42%)
DIS   92.69 (+0.21%)
AMC   6.65 (-7.39%)
PFE   30.44 (+1.20%)
PYPL   57.61 (-0.62%)
XOM   102.80 (+0.45%)
QQQ   388.83 (-0.25%)
AAPL   189.95 (+0.31%)
MSFT   378.91 (+0.02%)
META   327.15 (-1.52%)
GOOGL   132.53 (-1.82%)
AMZN   146.09 (-0.16%)
TSLA   240.08 (-1.66%)
NVDA   467.70 (-2.85%)
NIO   7.28 (+1.39%)
BABA   74.86 (+0.25%)
AMD   121.16 (-2.17%)
T   16.57 (+1.66%)
F   10.28 (-2.93%)
MU   76.12 (-0.74%)
CGC   0.56 (+0.00%)
GE   121.74 (+2.42%)
DIS   92.69 (+0.21%)
AMC   6.65 (-7.39%)
PFE   30.44 (+1.20%)
PYPL   57.61 (-0.62%)
XOM   102.80 (+0.45%)
QQQ   388.83 (-0.25%)
AAPL   189.95 (+0.31%)
MSFT   378.91 (+0.02%)
META   327.15 (-1.52%)
GOOGL   132.53 (-1.82%)
AMZN   146.09 (-0.16%)
TSLA   240.08 (-1.66%)
NVDA   467.70 (-2.85%)
NIO   7.28 (+1.39%)
BABA   74.86 (+0.25%)
AMD   121.16 (-2.17%)
T   16.57 (+1.66%)
F   10.28 (-2.93%)
MU   76.12 (-0.74%)
CGC   0.56 (+0.00%)
GE   121.74 (+2.42%)
DIS   92.69 (+0.21%)
AMC   6.65 (-7.39%)
PFE   30.44 (+1.20%)
PYPL   57.61 (-0.62%)
XOM   102.80 (+0.45%)
QQQ   388.83 (-0.25%)
AAPL   189.95 (+0.31%)
MSFT   378.91 (+0.02%)
META   327.15 (-1.52%)
GOOGL   132.53 (-1.82%)
AMZN   146.09 (-0.16%)
TSLA   240.08 (-1.66%)
NVDA   467.70 (-2.85%)
NIO   7.28 (+1.39%)
BABA   74.86 (+0.25%)
AMD   121.16 (-2.17%)
T   16.57 (+1.66%)
F   10.28 (-2.93%)
MU   76.12 (-0.74%)
CGC   0.56 (+0.00%)
GE   121.74 (+2.42%)
DIS   92.69 (+0.21%)
AMC   6.65 (-7.39%)
PFE   30.44 (+1.20%)
PYPL   57.61 (-0.62%)
XOM   102.80 (+0.45%)

Biomerica Stock Price, News & Analysis (NASDAQ:BMRA)

$0.93
+0.03 (+3.33%)
(As of 11/30/2023 ET)
Compare
Today's Range
$0.89
$0.94
50-Day Range
$0.71
$1.05
52-Week Range
$0.70
$4.04
Volume
6,514 shs
Average Volume
97,140 shs
Market Capitalization
$15.64 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

BMRA stock logo

About Biomerica Stock (NASDAQ:BMRA)

Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations. It primarily sells its products for gastrointestinal diseases, food intolerances, and various esoteric tests at the physicians' offices and over-the-counter drugstores, and hospital/clinical laboratories. The company is also developing InFoods IBS, that uses a simple blood sample to identify patient-specific foods which may alleviate irritable bowel syndrome symptoms; and H. Pylori diagnostic test that indicates if a patient is infected with the H. Pylori bacteria. In addition, it develops products to indicate if a person has been infected by COVID-19. Biomerica, Inc. was incorporated in 1971 and is headquartered in Irvine, California.

BMRA Stock Price History

BMRA Stock News Headlines

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
REPEAT - Biomerica Reports First Quarter 2024 Financial Results
Biomerica Reports First Quarter 2024 Financial Results
The Only Practical Solution to the World’s Looming Energy Crisis
There’s just one problem: There are more plans for new uses of nuclear than there is uranium to fuel the plants!
Biomerica reports FY results
Biomerica Reports Fiscal 2023 Year End Results
QRTEA, BIOC and AMTX among mid-day movers
Biomerica, Inc.: Biomerica Reports Q3 Fiscal 2023 Results
Biomerica Reports Q3 Fiscal 2023 Results
See More Headlines
Receive BMRA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Biomerica and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
10/12/2023
Today
11/30/2023
Next Earnings (Estimated)
1/12/2024
Fiscal Year End
5/31/2024

Industry, Sector and Symbol

Industry
Diagnostic substances
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:BMRA
Employees
62
Year Founded
1971

Profitability

Net Income
$-7,140,000.00
Net Margins
-114.52%
Pretax Margin
-113.19%

Debt

Sales & Book Value

Annual Sales
$5.34 million
Book Value
$0.70 per share

Miscellaneous

Free Float
14,551,000
Market Cap
$15.47 million
Optionable
Not Optionable
Beta
-0.64

Social Links

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

  • Mr. Zackary S. Irani (Age 57)
    Chairman & CEO
    Comp: $141.25k
  • Mr. Allen C. Barbieri (Age 65)
    Executive Vice-Chairman of the Board & Corporate Secretary
    Comp: $126.25k
  • Mr. Gary Lu CPA (Age 42)
    Principal Accounting Officer & CFO
    Comp: $260k
  • Ms. Lucy Liu Ph.D.
    Director of Manufacturing & Technical Operations
  • Hans Boehringer
    Senior Vice President of POC Research & Development
  • Mr. Robert W. Carlson
    Chief Commercial Officer














BMRA Stock Analysis - Frequently Asked Questions

How have BMRA shares performed in 2023?

Biomerica's stock was trading at $3.35 at the beginning of the year. Since then, BMRA shares have decreased by 72.2% and is now trading at $0.93.
View the best growth stocks for 2023 here
.

Are investors shorting Biomerica?

Biomerica saw a decline in short interest during the month of November. As of November 15th, there was short interest totaling 360,100 shares, a decline of 13.0% from the October 31st total of 414,100 shares. Based on an average daily volume of 53,600 shares, the days-to-cover ratio is presently 6.7 days.
View Biomerica's Short Interest
.

When is Biomerica's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, January 12th 2024.
View our BMRA earnings forecast
.

How were Biomerica's earnings last quarter?

Biomerica, Inc. (NASDAQ:BMRA) announced its quarterly earnings data on Thursday, October, 12th. The company reported ($0.07) EPS for the quarter. The company had revenue of $1.71 million for the quarter. Biomerica had a negative net margin of 114.52% and a negative trailing twelve-month return on equity of 69.43%.

What other stocks do shareholders of Biomerica own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Biomerica investors own include Sorrento Therapeutics (SRNE), Pfizer (PFE), Johnson & Johnson (JNJ), OPKO Health (OPK), TG Therapeutics (TGTX), Advanced Micro Devices (AMD), Co-Diagnostics (CODX), FuelCell Energy (FCEL) and Trevena (TRVN).

Who are Biomerica's major shareholders?

Biomerica's stock is owned by a variety of retail and institutional investors. Top institutional investors include Potomac Capital Management Inc. (1.02%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Allen Barbieri, Catherine Coste and Zackary S Irani.
View institutional ownership trends
.

How do I buy shares of Biomerica?

Shares of BMRA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:BMRA) was last updated on 11/30/2023 by MarketBeat.com Staff

My Account -